Tranilast

CAT:
804-HY-B0195-01
Size:
10 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Tranilast - image 1

Tranilast

  • Description :

    Tranilast (MK-341) acts as an anti-atopic agent. Tranilast suppresses production of prostaglandin D2 (PGD2, IC50= 0.1 mM) . Tranilast sodium exhibits anti-inflammatory and immunomodulatory effects[1]. Tranilast sodium antagonizes angiotensin II and inhibits its biological effects in vascular smooth muscle cells[2].
  • Product Name Alternative :

    MK-341; SB 252218
  • UNSPSC :

    12352005
  • Hazard Statement :

    H302, H315, H319, H335
  • Target :

    Angiotensin Receptor; Prostaglandin Receptor
  • Type :

    Reference compound
  • Related Pathways :

    GPCR/G Protein
  • Applications :

    COVID-19-immunoregulation
  • Field of Research :

    Inflammation/Immunology; Endocrinology; Cancer; Cardiovascular Disease
  • Assay Protocol :

    https://www.medchemexpress.com/Tranilast.html
  • Purity :

    99.95
  • Solubility :

    DMSO : 50 mg/mL (ultrasonic)
  • Smiles :

    O=C(O)C1=CC=CC=C1NC(/C=C/C2=CC=C(OC)C(OC)=C2)=O
  • Molecular Formula :

    C18H17NO5
  • Molecular Weight :

    327.33
  • Precautions :

    H302, H315, H319, H335
  • References & Citations :

    [1]K Ikai , et al. Inhibitory Effect of Tranilast on Prostaglandin D Synthetase. Biochem Pharmacol. 1989 Aug 15;38 (16) :2673-6.|[2]Sara Darakhshan, et al. Tranilast Enhances the Anti-Tumor Effects of Tamoxifen on Human Breast Cancer Cells in Vitro. J Biomed Sci. 2013 Oct 21;20 (1) :76.|[3]E A Capper, et al. Modulation of Human Monocyte Activities by Tranilast, SB 252218, a Compound Demonstrating Efficacy in Restenosis. J Pharmacol Exp Ther. 2000 Dec;295 (3) :1061-9.|[4]M Isaji , et al. Tranilast Inhibits the Proliferation, Chemotaxis and Tube Formation of Human Microvascular Endothelial Cells in Vitro and Angiogenesis in Vivo. Br J Pharmacol. 1997 Nov;122 (6) :1061-6.|[5]K Miyazawa , et al. Tranilast Antagonizes Angiotensin II and Inhibits Its Biological Effects in Vascular Smooth Muscle Cells. Atherosclerosis. 1996 Apr 5;121 (2) :167-73.
  • Shipping Conditions :

    Room Temperature
  • Storage Conditions :

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category :

    Reference compound1
  • Clinical Information :

    Launched
  • Isoform :

    DP
  • CAS Number :

    [53902-12-8]

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide